-
Featured
Favipiravir to Treat COVID-19: Q&A with Boris Juelg, MD, PhD
Boris Juelg, MD, PhD, an attending physician in the Division of Infectious Diseases at Massachusetts General Hospital and an assistant professor at Harvard Medical School, explains what is currently known about the drug favipiravir and why he is excited about its potential to treat COVID-19 patients.
-
Featured
Prone Positioning May Benefit Non-Intubated Patients with Severe COVID-19
Management of acute respiratory distress syndrome (ARDS) related to COVID-19 should prioritize lung-protective ventilation, but prone positioning may benefit patients with COVID-19 and hypoxemia who are not intubated.
-
Featured
Using Chloroquine to Treat COVID-19: Q&A with Raghu Chivukula, MD, PhD
Raghu Chivukula, MD, PhD, a physician-scientist in the Division of Pulmonary and Critical Care Medicine at Massachusetts General Hospital, explains what is currently known about chloroquine and its use to treat COVID-19 patients.
-
CT Should Not Be Used to Guide Ventilation in COVID-19 Respiratory Failure
According to Massachusetts Hospital researchers, the degree of abnormality on computed tomography in COVID-19 bears no consistent relationship to respiratory system mechanics.
-
No Evidence to Support Novel Mechanism of Hypoxemia in COVID-19
According to Massachusetts General Hospital clinicians, observations of hypoxemia in COVID-19 are entirely consistent with known mechanisms and do not require the invocation of novel processes specific to SARS-CoV-2.
-
Choice of Tidal Volume in COVID-19 Patients Without ARDS Should Be Individualized
Massachusetts General Hospital researchers find that there's reasonably strong evidence for low tidal volume ventilation in non-ARDS respiratory failure, although it is not without risks.
COVID-19 contributors
-
Boris D. Juelg, MD, PhD
Attending Physician, Division of Infectious Diseases, Massachusetts General Hospital, Assistant Professor, Harvard Medical School
Recent Article
Favipiravir to Treat COVID-19: Q&A with Boris Juelg, MD, PhD
-
Bryan Hayes, PharmD, DABAT, FAACT, FASHP
Assistant Professor of Emergency Medicine, Harvard Medical School, Senior Attending Pharmacist, Emergency Medicine and Toxicology, Massachusetts General Hospital
Recent Article
The Use of NSAIDs in COVID-19 Patients: Q&A with Bryan D. Hayes, PharmD -
Charles Corey Hardin, MD, PhD
Physician, Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Associate Professor of Medicine, Harvard Medical School, Physician Investigator, Pulmonary, Mass General Research Institute
Recent Article
No Evidence to Support Novel Mechanism of Hypoxemia in COVID-19
-
Elizabeth Louise Hohmann, MD
Staff Physician, Infectious Diseases Division, Massachusetts General Hospital, Chair and Physician Director, Partners Human Research Committees
Recent Article
Early Results of Remdesivir Trial Are Promising, But More Research Needed -
Katrina A. Armstrong, MD
Physician-in-Chief, Department of Medicine, Massachusetts General Hospital
Recent Article
Medical Grand Rounds: COVID-19 and Acute Kidney Injury
-
Louise C. Ivers, MD
Executive Director of the Mass General Center for Global Health, Associate Physician in the Division of Infectious Diseases
Recent Article
Medical Grand Rounds: COVID-19 in Low-Resourced Settings—Reaching for Global Health Equity -
Raghu Chivukula, MD, PhD
Physician-Scientist, Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital
Recent Article
Surfactant Worth Studying as Treatment for COVID-19–Related ARDS
